Personalized medicine for pancreatic cancer: a step in the right direction.
Ko
Andrew H
AH
Tempero
Margaret A
MA
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D033721:Equilibrative Nucleoside Transporter 1 / Q000032:analysis*; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D026901:Membrane Transport Proteins / Q000032:analysis; D010190:Pancreatic Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D033721:Equilibrative Nucleoside Transporter 1; D026901:Membrane Transport Proteins; C438649:SLC29A1 protein, human; C065171:cif nucleoside transporter; D003841:Deoxycytidine; D005472:Fluorouracil; D000093542:Gemcitabine